Log in to save to my catalogue

ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway

ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6624840

ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway

About this item

Full title

ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway

Publisher

London: Nature Publishing Group UK

Journal title

Nature cell biology, 2019-05, Vol.21 (5), p.579-591

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

It is well established that ferroptosis is primarily controlled by glutathione peroxidase 4 (GPX4). Surprisingly, we observed that p53 activation modulates ferroptotic responses without apparent effects on GPX4 function. Instead, ALOX12 inactivation diminishes p53-mediated ferroptosis induced by reactive oxygen species stress and abrogates p53-depe...

Alternative Titles

Full title

ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6624840

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6624840

Other Identifiers

ISSN

1465-7392

E-ISSN

1476-4679

DOI

10.1038/s41556-019-0305-6

How to access this item